Seminars in Hematology
Volume 42, Issue 2 , Pages 91-103 , April 2005

Natural killer cell receptors: Regulating innate immune responses to hematologic malignancy

  • Katharine C. Hsu

      Affiliations

    • Corresponding Author InformationAddress correspondence to Katharine C. Hsu, MD, PhD, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021
    • ,
  • Bo Dupont

References 

  1. Biron CA , Nguyen KB , Pien GC , Cousens LP , Salazar-Mather TP . Natural killer cells in antiviral defense (Function and regulation by innate cytokines) . Annu Rev Immunol . 1999;17:189–220
  2. Biron CA , Brossay L . NK cells and NKT cells in innate defense against viral infections . Curr Opin Immunol . 2001;13:458–464
  3. Biron CA , Nguyeny KB , Pein GC . Innate immune responses to LCMV infections (natural killer cells and cytokines) . Curr Top Microbiol Immunol . 2002;263:7–464
  4. Trinchieri G . Biology of natural killer cells . Adv Immunol . 1989;47:187–376
  5. Dupont B , Hsu KC . Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation . Curr Opin Immunol . 2004;16:1–10
  6. Cooper M , Fehniger T , Caligiuri M . The biology of human natural killer-cell subsets . Trends Immunol . 2001;22:633–640
  7. Cooper M , Fehniger T , Fuchs A , Colonna M , Caligiuri M . NK cell and DC interactions . Trends Immunol . 2004;25:47–52
  8. Ferlazzo G , Munz C . NK cell compartments and their activation by dendritic cells . J Immunol . 2004;172:1333–1339
  9. Lanier L , Le A , Civin C , Loken M , Phillips J . The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes . J Immunol . 1986;136:4480–4486
  10. Dalbeth N , Gundle R , Davies R , Lee Y , McMichael A , Callan M . CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation . J Immunol . 2004;173:6418–6426
  11. Ljunggren HG , Karre K . In search of the missing self (MHC molecules and NK recognition) . Immunol Today . 1990;11:237–244
  12. Shimuzu Y , DeMars R . Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression . Eur J Immunol . 1989;19:447–451
  13. Storkus W , Alexander J , Payne J , Dawson J , Cresswell P . Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes . Proc Natl Acad Sci U S A . 1989;86:2361–2364
  14. Hoglund P , Ljunggren HG , Karre K , Jay G . Role of major histocompatibility complex class-I molecules in tumor rejection . Immunol Res . 1990;9:298–313
  15. Ljunggren HG , Sturmhofel K , Wolpert E , Hammerling GJ , Karre K . Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants . J Immunol . 1990;145:380–386
  16. Tortorella D , Gewurz B , Furman M , Schust D , Ploegh H . Viral subversion of the immune system . Annu Rev Immunol . 2000;18:861–926
  17. Alcami A , Koszinowski U . Viral mechanisms of immune evasion . Immunol Today . 2000;9:447–455
  18. Rees R , Mian S . Selective MHC expression in tumours modulates adapative and innate antitumour responses . Cancer Immunol Immunother . 1999;7:374–381
  19. Diefenbach A , Jamieson AM , Liu SD , Shastri N , Raulet DH . Ligands for the murine NKG2D receptor (expression by tumor cells and activation of NK cells and macrophages) . Nat Immunol . 2000;1:119–126
  20. Diefenbach A , Jensen ER , Jamieson AM , Raulet DH . Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity . Nature . 2001;413:165–171
  21. Cerwenka A , O’Callaghan CA , Hamerman JA , Yadav R , Ajayi W , Roopenian DC , et al.   Cutting edge (the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2D) . J Immunol . 2002;168:3131–3134
  22. Cerwenka A , Baron JL , Lanier LL . Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo . Proc Natl Acad Sci U S A . 2001;98:11521–11526
  23. Moretta A , Bottino C , Vitale M , Pende D , Cantoni C , Mingari MC , et al.   Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis . Ann Rev Immunol . 2001;19:197
  24. Biassoni R , Cantoni C , Pende D , Sivori S , Parolini S , Vitale M , et al.   Human natural killer cell receptors and co-receptors . Immunol Rev . 2001;181:203–214
  25. Trowsdale J , Barten R , Haude A , Steward C , Beck S , Wilson M . The genomic context of natural killer receptor extended gene families . Immunol Rev . 2001;181:20–38
  26. Avril T , FLoyd H , Lopez F , Vivier E , Crocker P . The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells . J Immunol . 2004;173:6841–6849
  27. Vilches C , Parham P . KIR (Diverse, rapidly evolving receptors of innate and adaptive immunity) . Annu Rev Immunol . 2002;20:217–251
  28. Kulski J , Shiina T , Anzai T , Kohara S , Inoko H . Comparative genomic analysis of the MHC (the evolution of class I duplication blocks, diversity and complexity from shark to man) . Immunol Rev . 2002;190:95–122
  29. Kasahara M . The chromosomal duplication model of the major histocompatibility complex . Immunol Rev . 1999;167:17–32
  30. Hsu KC , Chida S , Dupont B , Geraghty DE . The killer cell immunoglobulin-like receptor (KIR) genomic region (Gene-order, haplotypes and allelic polymorphism) . Immunol Rev . 2002;190:40–52
  31. Hsu KC , Liu X , Selvakumar A , Mickelson E , O’Reilly RJ , Dupont B . Killer Ig-like receptor haplotype analysis by gene content (evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets) . J Immunol . 2002;169:5123–5134
  32. Yawata M , Yawata N , McQueen KL , Cheng NW , Guethlein LA , Rajalingam R , et al.   Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression . Immunogenetics . 2002;54:543–550
  33. Marsh SG , P.Parham BD , Geraghty DE , Trowsdale J , Middleton D , et al.   Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002 . Immunogenetics . 2003;55:220–226
  34. Shilling HG , Guethlein LA , Cheng NW , Gardiner CM , Rodriguez R , Tyan D , et al.   Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype . J Immunol . 2002;168: 2315–2307
  35. Goodridge J , Witt C , Christiansen F , Warren H . KIR2DL4 (CD158d) genotype influences expression and function in NK cells . J Immunol . 2003;171:1768–1774
  36. Pando MJ , Gardiner CM , Gleimer M , McQueen KL , Parham P . The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1 . J Immunol . 2003;171:6640–6649
  37. Vilches C , Gardiner CM , Parham P . Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene . J Immunol . 2000;165:6416–6421
  38. Gumperz J , Barber L , Valiante N , Percival L , Phillips J , Lanier L , et al.   Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor . J Immunol . 1997;158:5237–5241
  39. Cella M , Longo A , Ferrara G , Strominger J , Colonna M . NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with Isoleucine 80 . J Exp Med . 1994;180:1235–1242
  40. Uhrberg M , Valiante NM , Shum BP , Shilling HG , Lienert-Weidenbach K , Corliss B , et al.   Human diversity in killer cell inhibitory receptor genes . Immunity . 1997;7:753–763
  41. Valiante NM , Uhrberg M , Shilling HG , Lienert-Weidenbach K , Arnett KL , D’Andrea A , et al.   Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors . Immunity . 1997;7:739–751
  42. Crum KA , Logue SE , Curran MD , Middleton D . Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires . Tissue Antigens . 2000;56:313–326
  43. Norman PJ , Carrington CV , Byng M , Maxwell LD , Curran MD , Stephens HA , et al.   Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations . Genes Immun . 2002;3:86–95
  44. Norman PJ , Stephens HA , Verity DH , Chandanayingyong D , Vaughan RW . Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups . Immunogenetics . 2001;52:195–205
  45. Witt CS , Dewing C , Sayer DC , Uhrberg M , Parham P , Christiansen FT . Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination . Transplantation . 1999;68:1784–1789
  46. Toneva M , Lepage V , Lafay G , Dulphy N , Busson M , Lester S , et al.   Genomic diversity of natural killer cell receptor genes in three populations . Tissue Antigens . 2001;57:358–362
  47. Brown D , Trowsdale J , Allen R . The LILR family (modulators of innate and adaptive immune pathways in health and disease) . Tissue Antigens . 2004;64:215–225
  48. Chapman T , Heikema A , Bjorkman P . The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18 . Immunity . 1999;11:603–613
  49. Cosman N , Fanger N , Borges L , Kubin M , Chin W , Peterson L , et al.   A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules . Immunity . 1997;7:273–282
  50. Vitale M , Castriconi R , Parolini S , Pende D , Hsu M , Moretta L , et al.   The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles (analysis of LIR-1+NK cell clones) . Int Immunol . 1999;11:29–35
  51. Shiroishi M , Tsumoto K , Amano K , Shirakihara Y , Colonna M , Braud V , et al.   Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G . Proc Natl Acad Sci U S A . 2003;100:8856–8861
  52. Braud VM , Allan DS , O’Callaghan A , Soderstrom K , D’Andrea A , Ogg GS , et al.   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C . Nature . 1998;391:795–799
  53. Lee N , Llano M , Carretero M , Ishitani A , Navarro F , Lopez-Botet M , et al.   HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A . Proc Natl Acad Sci U S A . 1998;95:5199–5204
  54. Borrego B , Ulbrecht M , Weiss E , Coligan J , Brooks A . Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis . J Exp Med . 1998;187:813–818
  55. Kabat J , Borrego F , Brooks A , Coligan J . Role that each NKG2A immunoreceptor tyrosine-based inhibitory motif plays in mediating the human CD94/NKG2A inhibitory signal . J Immunol . 2002;169:1948–1958
  56. Vales-Gomez M , Reyburn H , Erskine R , Lopez-Botet M , Strominger J . Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E . EMBO J . 1999;18:4250–4260
  57. Gleimer M , Parham P . Stress management (MHC class I and class I-like molecules as reporters of cellular stress) . Immunity . 2003;19:469–477
  58. Bauer S , Groh V , Wu J , Steinle A , Phillips J , Lanier L , et al.   Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA . Science . 1999;285:727–729
  59. Bacon L , Eagle R , Meyer M , Easom N , Young N , Trowsdale J . Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D . J Immunol . 2004;173:1078–1084
  60. Radosavljevic M , Cuillerier B , Wilson M , Clement O , Wicker S , Gilfillan S , et al.   A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3 . Genomics . 2001;79:114–123
  61. Cosman D , Mullberg J , Sutherland C , Chin W , Armitage R , Fanslow W , et al.   ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor . Immunity . 2001;14:123–133
  62. Cerwenka A , Lanier L . NKG2D ligands (unconventional MHC class I-like molecules exploited by viruses and cancer) . Tissue Antigens . 2003;61:335–343
  63. Wu J , Song Y , Bakker A , Bauer S , Spies T , Lanier L , et al.   An activating immunoreceptor complex formed by NKG2D and DAP10 . Science . 1999;285:645–646
  64. Diefenbach A , Tomasello E , Lucas M , Jamieson A , Hsia J , Vivier E , et al.   Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D . Nat Immunol . 2002;3:1142–1149
  65. Gilfillan S , Ho E , Cella M , Yokoyama W , Colonna M . NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation . Nat Immunol . 2002;3:1150–1155
  66. Rosen D , Araki M , Hamerman J , Chen T , Yamamura T , Lanier L . J Immunol . 2004;173:2470–2478
  67. Bahram S . MIC genes (from genetics to biology) . Adv Immunol . 2000;76:1–60
  68. Groh V , Bahram S , Bauer S , Herman A , Beauchamp M , Spies T . Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointenstinal epithelium . Proc Natl Acad Sci U S A . 1996;93:12445–12450
  69. Groh V , Rhinehart R , Randolph-Habecker J , Topp M , Riddell S , Spies T . Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells . Nat Immunol . 2001;2:255–260
  70. Das H , Groh V , Kuijl C , Sugita M , Morita C , Spies T , et al.   MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function . Immunity . 2001;15:83–93
  71. Hue S , mention J , Monteiro R , Zhang S , Cellier C , Schmitz J , et al.   A direct role for NKG2D/MICA interacation in villous atrophy during celiac disease . Immunity . 2004;21:367–377
  72. Groh V , Bruhl A , El-Gabalawy H , Nelson J , Spies T . Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis . Proc Natl Acad Sci U S A . 2003;100:9452–9457
  73. Pende D , Cantoni C , Rivera P , Vitale M , Castriconi R , Marcenaro S , et al.   Role of NKG2D in tumor cell lysis mediated by human NK cells (cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin) . Eur J Immunol . 2001;31:1076–1086
  74. Groh V , Rhinehart R , Secrist H , Bauer S , Brabstein K , Spies T . Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB . Proc Natl Acad Sci U S A . 1999;96:6879–6884
  75. Welte S , Sinzger C , Lutz S , Singh-Jasuja H , Sampaio K , Eknigk U , et al.   Selective intracellular rentention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein . Eur J Immunol . 2003;33:194–203
  76. Sivori S , Vitale M , Morelli L , Sanseverino L , Augugliaro R , Bottino C , et al.   p46, a novel natural killer cell-specific surface molecule that mediates cell activation . J Exp Med . 1997;186:1129–1136
  77. Pende D , Parolini S , Pessino A , Sivori S , Augugliaro R , Morelli L , et al.   Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells . J Exp Med . 1999;190:1505–1516
  78. Vitale M , Bottino C , Sivori S , Sanseverino L , Castriconi R , Marcenaro E , et al.   NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis . J Exp Med . 1998;187:2065–2072
  79. Foster C , Colonna M , Sun P . Crystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors . J Biol Chem . 2003;278:46081–46086
  80. Salih HR , Antropius H , Gieseke F , Lutz SZ , Kanz L , Rammensee HG , et al.   Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia . Blood . 2003;102:1389–1396
  81. Doubrovina E , Doubrovin M , Vider E , Sisson R , O’Reilly R , Dupont B , et al.   Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma . J Immunol . 2003;171:6891–6899
  82. Salih H , Rammensee H , Steinle A . Cutting edge (Down-regulation of MICA on human tumors by proteolytic shedding) . J Immunol . 2002;169:4098–4102
  83. Groh V , Wu J , Yee C , Spies T . Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation . Nature . 2002;419:734–738
  84. Pende D , Spaggiari G , Marcenaro S , Martini S , Rivera P , Capobianco A , et al.   Analysis of the receptor-ligand interactions in the NK-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias (Evidence for the involvement of the poliovirus receptor (CD155) and Nectin-2 (CD112)) . Blood . 2005;105:2066–2073
  85. Carbone E , Neri P , Mesuraca M , Fulciniti M , Otsuki T , Pende D , et al.   HLA class I, NKG2D and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells . Blood . 2005;105:251–258
  86. Andre P , Castriconi R , Espeli M , Anfossi N , Juarez T , Hue S , et al.   Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors . Eur J Immunol . 2004;34:961–971
  87. Dupont B . Immunology of hematopoietic stem cell transplantation (A brief review of its history) . Immunol Rev . 1997;175:5–12
  88. Anasetti C , Amos D , Beatty P , Appelbaum F , Bensinger W , Buckner C , et al.   Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma . N Engl J Med . 1989;320:197–204
  89. Hansen J , Petersdorf E , Martin P , Anasetti C . Hematopoietic stem cell transplants from unrelated donors . Immunol Rev . 1997;175:141–151
  90. Petersdorf E , Anasetti C , Martin P , Booley T , Radich J , Malkki M , et al.   Limits of HLA mismatching in unrelated hematopoietic cell transplantation . Blood . 2004;104:2976–2980
  91. Flomenberg N , Baxter-Lowe L , Confer D , Fernandez-Vina M , Filipovich A , Horowitz M , et al.   Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation (HLA-C mismatching is associated with a strong adverse effect on transplantation outcome) . Blood . 2004;104:1923–1930
  92. Reisner Y , Kapoor N , Kirkpatrick D , Pollack M , Dupont B , Good R , et al.   Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells . Lancet . 1981;2:327–331
  93. van den Brink MR , Alpdogan O , Boyd R . Strategies to enhance T-cell reconstitution in immunocompromised patients . Nat Rev Immunol . 2004;4:856–867
  94. Aversa F , Tabilio A , Velardi A , Cunningham I , Terenzi A , Falzetti F , et al.   Treatment of high-risk acute leukemia with T-cell depleted stem cells from related donors with one fully mismatched HLA haplotype . N Engl J Med . 1998;339:1186–1193
  95. Ruggeri L , Capanni M , Urbani E , Perruccio K , Shlomchik WD , Tosti A , et al.   Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants . Science . 2002;295:2097–2100
  96. Leung W , Iyengar R , Turner V , Lang P , Bader P , Conn P , et al.   Determinants of antileukemia effects of allogeneic NK cells . J Immunol . 2004;172:644–650
  97. Cudkowicz G , Bennett M . Peculiar immunobiology of bone marrow allografts (I. Graft rejection by heavily irradiated “responder” mice) . J Exp Med . 1971;134:83–102
  98. Cudkowicz G , Bennett M . Peculiar immunobiology of bone marrow allografts (II. Rejection of parental grafts by F1 hybrid mice) . J Exp Med . 1971;135:1513–1528
  99. Ruggeri L , Capanni M , Casucci M , Volpi I , Tosti A , Perruccio K , et al.   Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation . Blood . 1999;94:333–339
  100. Davies SM , Ruggeri L , DeFor T , Wagner JE , Weisdorf DJ , Miller JS , et al.   Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants (Killer immunoglobulin-like receptor) . Blood . 2002;100:3825–3827
  101. Giebel S , Locatelli F , Lamparelli T , Velardi A , Davies S , Frumento G , et al.   Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors . Blood . 2003;102:814–819
  102. Beelen D , Ottinger H , Ferencik S , Elmaagacli H , Peceny R , Trenschel R , et al.   Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias . Blood . 2005;105:2594–2600
  103. Farag S , Bacigalupo A , Dupont B , Caligiuri M , Nelson G , Miller J , et al.   The effect of killer immunoglobulin-like receptor (KIR) ligand incompatibility on outcome of unrelated donor bone marrow transplantation (UDT) . Blood . 2004;104:434
  104. Lowe EJ , Turner V , Handgretinger R , Horwitz EM , Benaim E , Hale GA , et al.   T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell depleted HLA-non-identical paediatric bone marrow transplantation . Br J Haematol . 2003;123:323–326
  105. Nelson G , Martin M , Gladman D , Wade J , Trowsdale J , Carrington M . Cutting edge (heterozygote advantage in autoimmune disease: Hierarchy of protection/susceptibility conferred by HLA and killer Ig-likde receptor combinations in psoriatic arthritis) . J Immunol . 2004;173:4273–4276
  106. Khakoo S , Thio C , Martin M , Brooks C , Gao X , Astemborski J , et al.   HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection . Science . 2004;305:872–874
  107. Hsu K, Keever-Taylor C, Wilton A, Pinto C, Heller G, Arkun K, et al: Improved outcome in allogeneic hematopoietic stem cell transplantation in acute myelogenous leukemia (AML) predicted by donor KIR genotype and recipient HLA genotype in T-cell depleted HLA-identical sibling transplants. Blood First Edition Paper, prepublished online February 24, 2005; DOI 10.1182/blood-2004-12-4825
  108. Cook MA , Milligan DW , Fegan CD , Darbyshire PJ , Mahendra P , Craddock CF , et al.   The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia . Blood . 2004;103:1521–1526
  109. Sobecks R , Ball E , Rybicki L , Brown S , Kalaycio M , Pohlman B , et al.   Survival difference of AML patients receiving HLA matched sibling allogeneic bone marrow transplants (ABMT) correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors (KIRs) . Blood . 2004;103:4622; (abstr)
  110. Grau R , Lang KS , Wernet D , Lang P , Niethammer D , Pusch CM , et al.   Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals . Exp Mol Pathol . 2004;76:90–98

 Work from the authors’ laboratories is supported by grants form the National Institutes of Health (AI49213, AI50193, CA23766, CA08748, HL070053). K.C.H. is a recipient of the Amy Strelzer Manasevits Scholar Award from The Marrow Foundation.

PII: S0037-1963(05)00010-7

doi: 10.1053/j.seminhematol.2005.01.010

Seminars in Hematology
Volume 42, Issue 2 , Pages 91-103 , April 2005

Article Tools

* Image Usage & Resolution